Career Center
Loading...
FDA-BeiGene-ACPHS pharmacovigilance two-year fellowship
ACPHS-BeiGene-FDA
Overview This two-year fellowship in pharmacovigilance and medication safety is a collaboration of BeiGene, the US Food and Drug Administration (FDA) Office of Surveillance and Epidemiology (OSE) and Albany College of Pharmacy and Health Sciences (ACPHS). This partnership of a global pharmaceutical company with a regulatory agency and an academic institution will provide a rich and rewarding experience for the fellow. In addition, the three partners want to build on their individual strengths and common objectives to create a compelling project that will span the two years. BeiGene, a global, commercial-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. Our vision is to transform the biotechnology industry, creating impactful medicines that will be affordable and accessible to far more cancer patients around the world. Our mission is to build the first next-generation biotechnology company- one that expands the highest quality therapies to billions more people- through courage, persistent innovation, and challenging the status quo. Currently, employees are located in Asia-Pacific, United States and Europe. BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for the treatment of cancer. BeiGene is working to create combination solutions aimed at having both a meaningful and lasting impact on cancer patients. BeiGene continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer. At BeiGene, we are passionate about our people, science, and creating a lasting impact. These priorities are of utmost importance to our organization. We strive to build a global organization recognized for its impact in cancer research and drug development, talented people, and integrity. For more information, see www.beigene.com. FDA Office of Surveillance and Epidemiology (OSE) monitors and evaluates the safety profiles of drugs available to American consumers using a variety of tools and disciplines throughout the life cycle of the drugs. OSE maintains a system of postmarketing surveillance and risk assessment programs to identify adverse events that did not appear during the drug development process. OSE evaluates more than 2 million adverse event reports submitted every year to FDA's MedWatch program. Staff in the Office of Surveillance and Epidemiology use this information to identify drug safety concerns and recommend actions to improve product safety and protect the public health. The Regulatory Science Staff (RSS) in OSE is responsible for providing leadership, coordination, and support for OSE’s regulatory science activities in the areas of risk management, pharmacovigilance, medication error detection and prevention in addition to epidemiology and health informatics. The Regulatory Information System (RIS) Program under RSS manages mission critical systems (e.g., FDA Adverse Event Reporting System (FAERS) and the Phonetic and Orthographic Computer Analysis (POCA)), implements and maintains data standards required for coding and reporting safety data with medical accuracy and consistency, and leads innovative projects in the area of artificial intelligence to improve the day-to-day management and analysis safety reports. Since 1881, Albany College of Pharmacy and Health Sciences has been committed to the advancement of health care and the development of leaders in the profession of pharmacy. The College serves the educational needs of approximately 1,500 students across two campuses in Albany, NY and Colchester, VT. Pharmacy Practice faculty at ACPHS have enjoyed collaborative relationships with experiential sites offering experiences in medication safety and pharmacy informatics since 2004. The ACPHS component of the fellowship will provide a series of field-based experiences that will allow the fellow to participate in the diverse aspects of medication safety within institutional pharmacy practice and observe how these activities relate to pharmacovigilance, informatics, and regulatory issues that support safe medication use. Settings In the first year, the Fellow will work full time at BeiGene on campus at either Emeryville, CA, San Mateo, CA, or Ridgefield Park, NJ. Following that, the Fellow will spend four months at Albany College of Pharmacy and Health Sciences in Albany, NY. Finally, during the last eight-nine months, the Fellow will work at the FDA OSE, White Oak Campus, Silver Spring, Maryland. Candidates must be able to report to each of the three working sites (i.e. BeiGene, ACPHS and FDA) as required. Relocation support will not be provided. Objectives of the fellowship
Successful candidate will have
Candidate competencies
|
Application requirements
Application deadline November 30 2020, 5P EST |
Error
